Sriram Venkataraman - Net Worth and Insider Trading

Sriram Venkataraman Net Worth

The estimated net worth of Sriram Venkataraman is at least $1.1 Billion dollars as of 2024-11-13. Sriram Venkataraman is the Director, 10% Owner of Lantheus Holdings Inc and owns about 12,293,599 shares of Lantheus Holdings Inc (LNTH) stock worth over $1.0 Billion. Sriram Venkataraman is the Director, 10% Owner of OptiNose Inc and owns about 14,273,017 shares of OptiNose Inc (OPTN) stock worth over $9 Million. Sriram Venkataraman is also the Director, 10% Owner of RVL Pharmaceuticals PLC and owns about 1,032,995 shares of RVL Pharmaceuticals PLC (RVLPQ) stock worth over $103. Details can be seen in Sriram Venkataraman's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Sriram Venkataraman has not made any transactions after 2022-08-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Sriram Venkataraman

Sriram Venkataraman Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Sriram Venkataraman owns 6 companies in total, including OptiNose Inc (OPTN) , RVL Pharmaceuticals PLC (RVLPQ) , and Lantheus Holdings Inc (LNTH) among others .

Click here to see the complete history of Sriram Venkataraman’s form 4 insider trades.

Insider Ownership Summary of Sriram Venkataraman

Ticker	Comapny	Transaction Date	Type of Owner
OPTN	OptiNose Inc	2019-11-25	director & 10 percent owner
RVLPQ	RVL Pharmaceuticals PLC	2022-08-08	director & 10 percent owner
LNTH	Lantheus Holdings Inc	2017-03-17	director & 10 percent owner
		2016-08-05	director
		2021-08-09	Executive Vice President
		2021-08-09	Executive Vice President

Sriram Venkataraman Latest Holdings Summary

Sriram Venkataraman currently owns a total of 3 stocks. Among these stocks, Sriram Venkataraman owns 12,293,599 shares of Lantheus Holdings Inc (LNTH) as of March 17, 2017, with a value of $1.0 Billion and a weighting of 99.18%. Sriram Venkataraman owns 14,273,017 shares of OptiNose Inc (OPTN) as of November 25, 2019, with a value of $9 Million and a weighting of 0.82%. Sriram Venkataraman also owns 1,032,995 shares of RVL Pharmaceuticals PLC (RVLPQ) as of August 8, 2022, with a value of $103 and a weighting of 0%.

Latest Holdings of Sriram Venkataraman

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
LNTH	Lantheus Holdings Inc	2017-03-17	12,293,599	85.18	1,047,168,763
OPTN	OptiNose Inc	2019-11-25	14,273,017	0.60	8,625,184
RVLPQ	RVL Pharmaceuticals PLC	2022-08-08	1,032,995	0.00	103

Holding Weightings of Sriram Venkataraman

Sriram Venkataraman Form 4 Trading Tracker

According to the SEC Form 4 filings, Sriram Venkataraman has made a total of 0 transactions in Lantheus Holdings Inc (LNTH) over the past 5 years. The most-recent trade in Lantheus Holdings Inc is the sale of 3,000,000 shares on March 17, 2017, which brought Sriram Venkataraman around $37 Million.

According to the SEC Form 4 filings, Sriram Venkataraman has made a total of 1 transactions in OptiNose Inc (OPTN) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in OptiNose Inc is the sale of 1,250,000 shares on November 25, 2019, which brought Sriram Venkataraman around $11 Million.

According to the SEC Form 4 filings, Sriram Venkataraman has made a total of 2 transactions in RVL Pharmaceuticals PLC (RVLPQ) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in RVL Pharmaceuticals PLC is the acquisition of 8,000,000 shares on August 8, 2022, which cost Sriram Venkataraman around $12 Million.

Insider Trading History of Sriram Venkataraman

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Sriram Venkataraman Trading Performance

GuruFocus tracks the stock performance after each of Sriram Venkataraman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Sriram Venkataraman is -23%. GuruFocus also compares Sriram Venkataraman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Sriram Venkataraman within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Sriram Venkataraman's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Sriram Venkataraman

Average Return

Average return per transaction

Outperforming Transactions

0 out of 2 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	33.48
Relative Return to S&P 500(%)	33.79

Sriram Venkataraman Ownership Network

Ownership Network List of Sriram Venkataraman

No Data

Ownership Network Relation of Sriram Venkataraman

Sriram Venkataraman Owned Company Details

What does OptiNose Inc do?

Who are the key executives at OptiNose Inc?

Sriram Venkataraman is the director & 10 percent owner of OptiNose Inc. Other key executives at OptiNose Inc include Chief Legal Officer & Corp Sec Marino Michael F Iii , President & COO Ramy A Mahmoud , and Chief Accounting Officer Anthony J Krick .

OptiNose Inc (OPTN) Insider Trades Summary

Over the past 18 months, Sriram Venkataraman made no insider transaction in OptiNose Inc (OPTN). Other recent insider transactions involving OptiNose Inc (OPTN) include a net sale of 229,564 shares made by Ramy A Mahmoud , a net sale of 83,902 shares made by Marino Michael F Iii , and a net sale of 9,814 shares made by Anthony J Krick .

In summary, during the past 3 months, insiders sold 8,107 shares of OptiNose Inc (OPTN) in total and bought 0 shares, with a net sale of 8,107 shares. During the past 18 months, 323,280 shares of OptiNose Inc (OPTN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 323,280 shares.

OptiNose Inc (OPTN)'s detailed insider trading history can be found in Insider Trading Tracker table.

OptiNose Inc Insider Transactions

No Available Data

What does RVL Pharmaceuticals PLC do?

Who are the key executives at RVL Pharmaceuticals PLC?

Sriram Venkataraman is the director & 10 percent owner of RVL Pharmaceuticals PLC. Other key executives at RVL Pharmaceuticals PLC include 10 percent owner Foundation Harsaul , 10 percent owner Altchem Ltd , and 10 percent owner Athyrium Opportunities Associates Iv Co-invest Llc .

RVL Pharmaceuticals PLC (RVLPQ) Insider Trades Summary

Over the past 18 months, Sriram Venkataraman made no insider transaction in RVL Pharmaceuticals PLC (RVLPQ). Other recent insider transactions involving RVL Pharmaceuticals PLC (RVLPQ) include a net sale of 17,544,196 shares made by Foundation Harsaul , and a net sale of 17,544,196 shares made by Altchem Ltd .

In summary, during the past 3 months, insiders sold 0 shares of RVL Pharmaceuticals PLC (RVLPQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 35,088,392 shares of RVL Pharmaceuticals PLC (RVLPQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 35,088,392 shares.

RVL Pharmaceuticals PLC (RVLPQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

RVL Pharmaceuticals PLC Insider Transactions

No Available Data

What does Lantheus Holdings Inc do?

Who are the key executives at Lantheus Holdings Inc?

Sriram Venkataraman is the director & 10 percent owner of Lantheus Holdings Inc. Other key executives at Lantheus Holdings Inc include director & CEO and President Mary Anne Heino , See Remarks Daniel Niedzwiecki , and Chief Commercial Officer Paul Blanchfield .

Lantheus Holdings Inc (LNTH) Insider Trades Summary

Over the past 18 months, Sriram Venkataraman made no insider transaction in Lantheus Holdings Inc (LNTH). Other recent insider transactions involving Lantheus Holdings Inc (LNTH) include a net sale of 6,661 shares made by Andrea Sabens , a net sale of 26,110 shares made by Paul Blanchfield , and a net sale of 138,561 shares made by Mary Anne Heino .

In summary, during the past 3 months, insiders sold 14,987 shares of Lantheus Holdings Inc (LNTH) in total and bought 0 shares, with a net sale of 14,987 shares. During the past 18 months, 320,236 shares of Lantheus Holdings Inc (LNTH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 320,236 shares.

Lantheus Holdings Inc (LNTH)'s detailed insider trading history can be found in Insider Trading Tracker table.

Lantheus Holdings Inc Insider Transactions

No Available Data

What does AngioDynamics Inc do?

Who are the key executives at AngioDynamics Inc?

Sriram Venkataraman is the director of AngioDynamics Inc. Other key executives at AngioDynamics Inc include SVP Quality and Regulatory Warren Jr Nighan , SVP and General Counsel Stephen A Trowbridge , and director & President and CEO James C Clemmer .

AngioDynamics Inc (ANGO) Insider Trades Summary

Over the past 18 months, Sriram Venkataraman made no insider transaction in AngioDynamics Inc (ANGO). Other recent insider transactions involving AngioDynamics Inc (ANGO) include a net purchase of 30,000 shares made by James C Clemmer , a net purchase of 1,700 shares made by Stephen A Trowbridge , and a net purchase of 868 shares made by Warren Jr Nighan .

In summary, during the past 3 months, insiders sold 0 shares of AngioDynamics Inc (ANGO) in total and bought 22,568 shares, with a net purchase of 22,568 shares. During the past 18 months, 0 shares of AngioDynamics Inc (ANGO) were sold and 32,568 shares were bought by its insiders, resulting in a net purchase of 32,568 shares.

AngioDynamics Inc (ANGO)'s detailed insider trading history can be found in Insider Trading Tracker table.

AngioDynamics Inc Insider Transactions

No Available Data

What does Avista Public Acquisition Corp II do?

Who are the key executives at Avista Public Acquisition Corp II?

Sriram Venkataraman is the Executive Vice President of Avista Public Acquisition Corp II. Other key executives at Avista Public Acquisition Corp II include director & 10 percent owner David F Burgstahler , director & 10 percent owner Thompson Dean , and director & 10 percent owner Avista Acquisition Gp Llc Ii .

Avista Public Acquisition Corp II (AHPA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Avista Public Acquisition Corp II (AHPA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Avista Public Acquisition Corp II (AHPA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Avista Public Acquisition Corp II (AHPA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Avista Public Acquisition Corp II Insider Transactions

No Available Data

What does OmniAb Inc do?

Who are the key executives at OmniAb Inc?

Sriram Venkataraman is the Executive Vice President of OmniAb Inc. Other key executives at OmniAb Inc include director & President & CEO Matthew W Foehr , EVP & Finance and CFO Kurt A Gustafson , and See Remarks Charles S Berkman .

OmniAb Inc (OABI) Insider Trades Summary

Over the past 18 months, Sriram Venkataraman made no insider transaction in OmniAb Inc (OABI). Other recent insider transactions involving OmniAb Inc (OABI) include a net purchase of 920,000 shares made by Matthew W Foehr , a net sale of 60,000 shares made by John L Higgins , and a net sale of 18,803 shares made by Kurt A Gustafson .

In summary, during the past 3 months, insiders sold 0 shares of OmniAb Inc (OABI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 85,757 shares of OmniAb Inc (OABI) were sold and 920,000 shares were bought by its insiders, resulting in a net purchase of 834,243 shares.

OmniAb Inc (OABI)'s detailed insider trading history can be found in Insider Trading Tracker table.

OmniAb Inc Insider Transactions

No Available Data

Sriram Venkataraman Mailing Address

Above is the net worth, insider trading, and ownership report for Sriram Venkataraman. You might contact Sriram Venkataraman via mailing address: C/o Avista Capital Partners, 65 East 55th Street, 18th Floor, New York Ny 10022.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.